As you point out, this space is heating up - especially with the GILD/FTSV acquisition early in the year. At a bare minimum we are a valuation gap play, and there is plenty of room to run here.
Assuming the market doesn't crumble, I personally could see this climbing into the double digits and could go vertical based on the 621 mid-year read out. If the data is positive with additional CRs/PRs, this may start a bidding war for those who lost out on the $4.9B GILD/FTSV deal ($95.50 pps). If TRIL fetched $2.5B, we would be sitting at roughly $30. Wouldn't complain, but it's very possible that GILD bought the wrong CD47 company, and if 621 and 622 continue to show statistically meaningful data, this company could be on par or have a greater valuation than FTSV.
Time will tell... thanks for sharing your thoughts. That's what this board is all about!
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM